Tests a DNA methylation signature for thyroid cancer in patients with thyroid nodules
Studies a DNA test for detecting thyroid cancer in people with thyroid nodules.
Plain-language title generated from the registry record
Registry title: Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Key facts
- Where
- Duarte, United StatesSee the site
Where in United States
- City of Hope Medical CenterDuarte, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- City of Hope Medical Center
- Trial code
- NCT03676647
- Record updated
- 2 June 2026
- Original description
This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.Read full original descriptionShow less
Retrospective-Prospective Collection of Thyroid Specimens After FNA
This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.
Inclusion: All patients undergoing FNA for thyroid nodule diagnosis; Any race and ethnicity are eligible for the study; Patient should have thyroid nodule(s) with indeterminate diagnosis after FNA (Bethesda category of indeterminate FNA [III-V]).